Market News
Latest news from Stock markets.
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today presented the first data for casdatifan plus cabozantinib in an oral presentation by Dr. Toni K. Choueiri, Dana-Farber Cancer Institute, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. “I was very encouraged to see that nearly half of patients had a.
...keep reeding on businesswire.com
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
SOUTH SAN FRANCISCO, Calif., June 01, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, presented updated data from the Phase 1 TRAVERSE study of ALLO-316 in renal cell carcinoma (RCC) during an oral presentation at the 2025 ASCO Annual Meeting. The Phase 1 TRAVERSE trial enrolled patients with advanced or metastatic renal cell RCC. Leveraging the proprietary Dagger® technology to enable robust CAR T cell expansion, it stands as the first and only allogeneic CAR T product to show promise in treating solid tumors. The presentation focused on the Phase 1b expansion cohort from the Phase 1 TRAVERSE study in which patients were treated with a standard regimen of cyclophosphamide and fludarabine followed by a single dose of 80 million AlloCAR T™ cells.
...keep reeding on globenewswire.com
SKYY: The Best ETF For The Cloud Expansion
Cloud computing is rapidly expanding, with only 30% of workloads migrated and a projected 22% CAGR through 2030, making the sector highly attractive. I favor SKYY ETF for long-term investors due to its superior historical performance, strong liquidity, and balanced exposure to cloud market leaders and tech giants. SKYY's emphasis on mega-cap tech firms like MSFT, AMZN, and GOOGL provides diversification, lower volatility, and a safer investment profile than pure-play cloud ETFs.
...keep reeding on seekingalpha.com
Shareholders of Napco Security Technologies, Inc. (NSSC): Protect Your Rights Before June 24, 2025 - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=151172&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
Broadcom to pay dividends on June 27; Here's how much 100 AVGO shares will earn
American semiconductor giant Broadcom (NASDAQ: AVGO) will pay its dividend on June 27, continuing its impressive streak of rewarding shareholders.
...keep reeding on finbold.com
Bank of America As A High-Yielding Income Idea
Bank of America's Q1 results were robust, with preferred dividends well covered at less than 6% of net income, enhancing income security. I favor the Series QQ preferred shares (BAC.PR.Q) for their 6.3% yield, attractive entry price, and strong coverage despite being non-cumulative. The Series QQ now offers a slightly higher yield than the Series L "busted" preferreds, making QQ marginally more attractive for new income positions.
...keep reeding on seekingalpha.com
June 2025 Watchlist: Best Ancillary Cannabis Stocks for Smart Investors
The U.S. cannabis industry continues to expand, even with ongoing regulatory challenges. In 2025, the market is projected to generate over $45 billion in revenue. Consumer demand is rising, and dispensary numbers continue to grow across the country. By 2030, the market could exceed $75 billion, driven by both medical and recreational use. So far, 24 states and Washington, D.C., have legalized recreational cannabis. In addition, 39 states allow it for medical purposes. However, federal prohibition still limits banking access and interstate commerce. Despite this, ancillary companies play a vital role. These firms do not touch the plant but support cultivation, production, and distribution. As the industry matures, these businesses offer more stability. For that reason, investors are closely watching key ancillary stocks this week.
...keep reeding on marijuanastocks.com
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151171&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
Investor Alert: Deadline Approaching to Join Iovance Biotherapeutics, Inc. (IOVA) Class Action - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151169&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
Levi & Korsinsky Notifies Avis Budget Group, Inc. (CAR) Shareholders of Class Action Lawsuit and June 24, 2025 Deadline
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=151164&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors - Lead Plaintiff Deadline June 3, 2025
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=151165&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
Class Action Lawsuit Filed: Krispy Kreme, Inc. (DNUT) - Join by July 15, 2025 - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=151167&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
Investors Urged to Contact Levi & Korsinsky for Information Before June 30, 2025 - Open Lending Corporation (LPRO)
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=151170&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
Levi & Korsinsky Urges Bitfarms Ltd. (BITF) Shareholders to Act Before Lead Plaintiff Deadline July 8, 2025
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=151166&wire=1&utm_campaign=19 or contact Joseph E.
...keep reeding on accessnewswire.com
July 21, 2025 Deadline Approaching: Join Class Action Against DoubleVerify Holdings, Inc. (DV) - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151163&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Zenas BioPharma, Inc. (ZBIO) Investors of June 16, 2025 Deadline
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151168&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.
...keep reeding on accessnewswire.com
ECG DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Everus Construction Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – ECG
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Everus Construction Group, Inc. (NYSE: ECG) between October 31, 2024 and February 11, 2025, both dates inclusive (the “Class Period”), including investors who held MDU Resources Group, Inc. (“MDU Resources”) common stock as of October 21, 2024 and acquired Everus Construction common stock issued in connection with the spinoff of Everus Construction on or about October 31, 2024 (the “Spinoff”), of the important June 3, 2025 lead plaintiff deadline.
...keep reeding on globenewswire.com
Ford's Yield Tops 7%
Ford's Dividend Is Extremely High The Company's Management Has Stumbled Take this quiz to see if you're on track to retire.
...keep reeding on 247wallst.com
Wall Street Brunch: Has Tariff Uncertainty Hit The Labor Market?
Investors are closely watching Fed policy and the May jobs report, as hiring appetite remains tepid amid macro uncertainty and tariff impacts. Broadcom and CrowdStrike earnings are key this week; AVGO benefits from AI demand, while CRWD sees cross-selling momentum and stable sector trends.
...keep reeding on seekingalpha.com
Global Indemnity: Getting Its House In Order
Recent California wildfires caused record-breaking insured losses, directly impacting Global Indemnity's Q1 2025 results. Despite the setback, the company's underlying business remains intact, though pricing risk should remain a concern for investors. The controlling shareholder received additional shares, however this particular class of equity is like a restricted stock and an option, converting if the market value hits a higher threshold.
...keep reeding on seekingalpha.com
Fraud Investigation: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE) on Behalf of Shareholders
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible violations of federal securities laws. NeuroPace issued a press release on May 27, 2025, "announc[ing] the preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for treatment of individuals with drug-resistant idiopathic generalized epilepsy (IGE).
...keep reeding on accessnewswire.com
Fraud Investigation Opened: Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) on Behalf of Shareholders
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tempus AI, Inc. ("Tempus AI, Inc.") (NASDAQ:TEM) concerning possible violations of federal securities laws. Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company.
...keep reeding on accessnewswire.com
Recover Investment Losses: Levi & Korsinsky Files Class Action Against UroGen Pharma Ltd. (URGN)
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151160&wire=1&utm_campaign=24 or contact Joseph E.
...keep reeding on accessnewswire.com
Ongoing Investigation: Rocket Pharmaceuticals, Inc. (RCKT) May Have Misled Shareholders - Levi & Korsinsky Investigates
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announc[ing] an update related to RP-A501, its investigational gene therapy for Danon disease.
...keep reeding on accessnewswire.com
CGDV: Forget The Yield, This Active Dividend Value ETF Just Works
CGDV is a top-performing actively managed fund run by a team of five managers with extensive industry experience. Its expense ratio is 0.33% and CGDV has $16.68 billion in assets. Income is not the focus, despite a name that suggests otherwise. However, if readers can focus instead on total returns, they'll see that CGDV offers excellent and diversified factor mix. For example, CGDV's 52-stock portfolio has a 13.44% one-year estimated EPS growth rate on average, and net and free cash flow margins of 19.95% and 17.48%, respectively.
...keep reeding on seekingalpha.com
TMCI Deadline: Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024. Treace Medical describes itself as a “medical technology company focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities.” For more information, submit a form, email attorney Phillip K.
...keep reeding on businesswire.com
Google, DOJ give closing arguments in antitrust case. What prosecutors could be eyeing next
The Department of Justice and Alphabet's Google (GOOG, GOOGL) are giving their closing remarks in the monopoly case against the tech giant on Friday, with federal prosecutors focusing more on aspects of Chrome and Google's search deals and data sharing. Chamber of Progress founder and CEO Adam Kovacevich joins Catalysts to explain how the government is expanding the case beyond Google's search business to target artificial intelligence (AI)-related issues.
...keep reeding on youtube.com
These 5 Special Dividends Are More Than Meets The Eye
Most mainstream financial websites are not “smart enough” to include special dividends. The yields they display reflect plain ol' quarterly or monthly payouts.
...keep reeding on forbes.com
Pomerantz Law Firm Announces the Filing of a Class Action Against BigBear.ai Holdings, Inc. and Certain Officers - BBAI
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against BigBear.ai Holdings, Inc. ("BigBear" or the "Company") (NYSE: BBAI) and certain officers. The class action, filed in the United States District Court for the Eastern District of Virginia , and docketed under 25-cv-00623, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
...keep reeding on prnewswire.com
Bronstein, Gewirtz & Grossman, LLC Encourages Arconic Corporation (ARNC) Shareholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arconic Corporation ("Arconic" or "the Company") (NYSE:ARNC). Investors who purchased Arconic securities prior to April 19, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ARNC.
...keep reeding on accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Meta Platforms, Inc. (META) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. ("Meta" or "the Company") (NASDAQ:META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/META.
...keep reeding on accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN).
...keep reeding on prnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Innodata Inc. (INOD) And Encourages Shareholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INOD.
...keep reeding on accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Grocery Outlet Holding Corp. (GO) And Encourages Shareholders to Reach Out
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Grocery Outlet Holding Corp. ("Grocery Outlet" or "the Company") (NASDAQ:GO). Investors who purchased Grocery Outlet securities prior to April 9, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GO.
...keep reeding on accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meta Platforms, Inc. - META
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meta Platforms, Inc. ("Meta" or the "Company") (NASDAQ: META). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. ("Viatris" or the "Company") (NASDAQ: VTRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flowco Holdings Inc. - FLOC
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Flowco Holdings Inc. ("Flowco" or the "Company") (NYSE: FLOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Extreme Networks, Inc. (EXTR) And Encourages Shareholders to Connect
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EXTR.
...keep reeding on accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - DDD
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE: DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
Pomerantz Law Firm Announces the Filing of a Class Action Against NET Power Inc. and Certain Officers - NPWR
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against NET Power Inc. ("Net Power" or the "Company") (NYSE: NPWR) and certain officers. The class action, filed in the United States District Court for the Middle District of North Carolina, and docketed under 25-cv-00296, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Net Power securities between June 9, 2023 and March 7, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
...keep reeding on prnewswire.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amylyx Pharmaceuticals, Inc. ("Amylyx" or "the Company") (NASDAQ:AMLX). Investors who purchased Amylyx securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AMLX.
...keep reeding on accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Globe Life Inc. (GL) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.
...keep reeding on accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Coinbase Global, Inc.- COIN
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Coinbase Global, Inc. ("Coinbase" or the "Company") (NASDAQ: COIN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EchoStar Corporation - SATS
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EchoStar Corporation ("EchoStar" or the "Company") (NASDAQ: SATS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on prnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Stockholders to Reach Out
NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PACS.
...keep reeding on accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bakkt Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - BKKT
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bakkt Holdings, Inc. ("Bakkt" or the "Company") (NYSE: BKKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on prnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE). Investors who purchased Sage securities prior to April 12, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SAGE.
...keep reeding on accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FTI Consulting, Inc. - FCN
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FTI Consulting, Inc. ("FTI" or the "Company") (NYSE: FCN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZBIO
NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on prnewswire.com